ZYLET Reviews (LOTEPREDNOL ETABONATE; TOBRAMYCIN)

Average Rating: 2.0 (2 Ratings)

Filter Results

Compare ZYLET with similar:

 Type: Rx Drug

  

ZYLET  (LOTEPREDNOL ETABONATE; TOBRAMYCIN):  This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. This product contains tobramycin, an antibiotic that works by stopping the growth of bacteria. It also contains loteprednol, an anti-inflammatory corticosteroid that works by reducing swelling, redness, and itching. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (e.g., infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.   FDA Approval Date: 2004-12-14 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR ZYLETCOMMENTSSEXAGEDURATION/
DOSAGE		DATE ADDED
 
 1  Eye itch Redness,itch, pain, eye discharge (white) eye Shrink. Dangerous side effects! It made a mild infection 100 times worse. F 79 0 days
1mg /5ml		 10/29/2021
Email
 3  Dry eye w/ contact irritation F 29
1 drop 1X day		 10/13/2012
Email

Patient History
  

ZYLET  (LOTEPREDNOL ETABONATE; TOBRAMYCIN):  This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. This product contains tobramycin, an antibiotic that works by stopping the growth of bacteria. It also contains loteprednol, an anti-inflammatory corticosteroid that works by reducing swelling, redness, and itching. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (e.g., infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.   FDA Approval Date: 2004-12-14 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP